Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ABLYNX NV”

22 pharma patents match "ABLYNX NV" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 22
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 22 pharmaceutical patents matching "ABLYNX NV" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

22 results for “ABLYNX NV” · 30,257 patents in full index Clear search

  1. WO 2026078159

    AGENTS D'ACTIVATION DE CELLULES IMMUNITAIRES ET PROCÉDÉS LES COMPRENANT

    ABLYNX NV [BE] · Granted Apr 16, 2026 · Expires Apr 11, 2046

    granted
  2. WO 2025262150

    MOLÉCULES DE RECRUTEMENT D'ANTICORPS

    ABLYNX NV [BE] · Granted Dec 26, 2025 · Expires Dec 21, 2045

    granted
  3. AR 133055

    DOMINIOS VARIABLES ÚNICOS DE INMUNOGLOBULINA DIRIGIDOS A PD-L1

    ABLYNX NV [BE] · Granted Aug 20, 2025 · Expires Aug 15, 2045

    granted
  4. MX 2025007399

    PROTEIN-BASED CONJUGATION CARRIERS

    ABLYNX NV [BE] · Granted Aug 1, 2025 · Expires Jul 27, 2045

    granted
  5. WO 2025133252

    DOMAINES VARIABLES UNIQUES D'IMMUNOGLOBULINE CIBLANT CEACAM5

    ABLYNX NV [BE] · Granted Jun 26, 2025 · Expires Jun 21, 2045

    granted
  6. WO 2025133253

    EXCIPIENTS DE CONJUGAISON PROTÉINIQUES POUR ADMINISTRATION INTRANUCLÉAIRE

    ABLYNX NV [BE] · Granted Jun 26, 2025 · Expires Jun 21, 2045

    granted
  7. WO 2025133166

    VÉHICULES À BASE DE PROTÉINES POUR CONJUGAISON D'AMINE SPÉCIFIQUE À UN SITE

    ABLYNX NV [BE] · Granted Jun 26, 2025 · Expires Jun 21, 2045

    granted
  8. WO 2025114529

    ANTICORPS MULTISPÉCIFIQUES RECONNAISSANT L'ALBUMINE SÉRIQUE HUMAINE, TCR ET FRACTION RECONNAISSANT L'ANTIGÈNE TUMORAL

    ABLYNX NV [BE] · Granted Jun 5, 2025 · Expires May 31, 2045

    granted
  9. US 2025129145

    BI- AND MULTIVALENT ALBUMIN BINDERS

    ABLYNX NV [BE] · Granted Apr 24, 2025 · Expires Apr 19, 2045

    granted
  10. US 2025034260

    FCRN ANTAGONISTS FOR TREATMENT OF IGG-RELATED DISEASES AND DISORDERS

    ABLYNX NV [BE] · Granted Jan 30, 2025 · Expires Jan 25, 2045

    granted
  11. WO 2024261235

    PROTÉINES CHIMÉRIQUES POUR MODULER L'ACTIVITÉ D'UN RÉCEPTEUR DE CYTOKINE

    ABLYNX NV [BE] · Granted Dec 26, 2024 · Expires Dec 21, 2044

    granted
  12. US 2024368250

    POLYPEPTIDES BINDING TO THE NEONATAL FC RECEPTOR

    ABLYNX NV [BE] · Granted Nov 7, 2024 · Expires Nov 2, 2044

    granted
  13. NZ 743471

    Improved immunoglobulin variable domains

    ABLYNX NV · Granted Jul 26, 2024 · Expires Jul 21, 2044

    granted
  14. WO 2024133935

    EXCIPIENTS DE CONJUGAISON PROTÉIQUES

    ABLYNX NV [BE] · Granted Jun 27, 2024 · Expires Jun 22, 2044

    granted
  15. US 2024166750

    GLYCOENGINEERED Fc VARIANT POLYPEPTIDES WITH ENHANCED EFFECTOR FUNCTION

    ABLYNX NV [BE] · Granted May 23, 2024 · Expires May 18, 2044

    granted
  16. EP 4350345

    VERFAHREN ZUR VORHERSAGE, ERKENNUNG UND REDUZIERUNG VON ASPEZIFISCHER PROTEININTERFERENZ IN TESTS MIT VARIABLEN IMMUNGLOBULIN-EINZELDOMÄNEN

    ABLYNX NV [BE] · Granted Apr 10, 2024 · Expires Apr 5, 2044

    granted
  17. CA 3259417

    DOMAINES VARIABLES UNIQUES D'IMMUNOGLOBULINE CIBLANT LE RÉCEPTEUR DES LYMPHOCYTES T

    ABLYNX NV [BE] · Granted Dec 21, 2023 · Expires Dec 16, 2043

    granted
  18. CN 116783219

    T cell recruitment polypeptides based on TCR alpha/beta reactivity

    ABLYNX NV · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted
  19. CA 3242445

    POLYPEPTIDES COMPRENANT DES DOMAINES VARIABLES UNIQUES D'IMMUNOGLOBULINE CIBLANT TCRAS, CD33 ET CD123

    ABLYNX NV [BE] · Granted Jun 22, 2023 · Expires Jun 17, 2043

    granted
  20. AR 124426

    POLIPÉPTIDOS QUE COMPRENDEN DOMINIOS VARIABLES ÚNICOS DE INMUNOGLOBULINA QUE SE DIRIGEN A IL-6 Y TNF-a

    ABLYNX NV [BE] · Granted Mar 29, 2023 · Expires Mar 24, 2043

    granted
  21. AR 124425

    POLIPÉPTIDOS QUE COMPRENDEN DOMINIOS VARIABLES SIMPLES DE INMUNOGLOBULINA DIRIGIDOS A GLYPICAN-3 Y AL RECEPTOR DE CÉLULAS T

    ABLYNX NV [BE] · Granted Mar 29, 2023 · Expires Mar 24, 2043

    granted
  22. AR 124446

    POLIPÉPTIDOS RECLUTADORES DE CÉLULAS T BASADOS EN LA REACTIVIDAD DE TCR a / b

    ABLYNX NV [BE] · Granted Mar 29, 2023 · Expires Mar 24, 2043

    granted